Cadinha & Co’s Pfizer PFE Stock Holding History

Cadinha & Co’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$303K	Hold	12,566	–	–	0.04%	83
2026 Q1	$353K	Hold	12,566	–	–	0.07%	72
2025 Q4	$313K	Sell	12,566 -5,955	-32%	-$150K	0.05%	77
2025 Q3	$472K	Hold	18,521	–	–	0.06%	69
2025 Q2	$449K	Sell	18,521 -695	-4%	-$16.2K	0.07%	65
2025 Q1	$487K	Sell	19,216 -93	-0.5%	-$2.43K	0.1%	56
2024 Q4	$512K	Sell	19,309 -32	-0.2%	-$868	0.09%	62
2024 Q3	$560K	Hold	19,341	–	–	0.1%	59
2024 Q2	$541K	Sell	19,341 -4,659	-19%	-$128K	0.1%	59
2024 Q1	$666K	Sell	24,000 -12,189	-34%	-$338K	0.11%	58
2023 Q4	$1.04M	Sell	36,189 -1,000	-3%	-$30.2K	0.17%	52
2023 Q3	$1.23M	Buy	37,189 +393	+1%	+$13.9K	0.27%	41
2023 Q2	$1.35M	Sell	36,796 -510	-1%	-$19.9K	0.25%	40
2023 Q1	$1.52M	Sell	37,306 -345,008	-90%	-$14.9M	0.42%	33
2022 Q4	$19.6M	Buy	382,314 +346,807	+977%	+$16.6M	4.37%	11
2022 Q3	$1.55M	Sell	35,507 -231	-0.6%	-$11.2K	0.52%	24
2022 Q2	$1.87M	Hold	35,738	–	–	0.42%	27
2022 Q1	$1.85M	Buy	35,738 +231	+0.7%	+$12K	0.27%	42
2021 Q4	$2.1M	Hold	35,507	–	–	0.28%	40
2021 Q3	$1.53M	Hold	35,507	–	–	0.22%	49
2021 Q2	$1.39M	Hold	35,507	–	–	0.19%	55
2021 Q1	$1.29M	Buy	35,507 +593	+2%	+$21.1K	0.19%	56
2020 Q4	$1.28M	Sell	34,914 -2,810	-7%	-$103K	0.18%	56
2020 Q3	$1.31M	Buy	37,724 +257	+0.7%	+$9.01K	0.23%	45
2020 Q2	$1.16M	Hold	37,467	–	–	0.2%	51
2020 Q1	$1.16M	Sell	37,467 -7,783	-17%	-$265K	0.31%	39
2019 Q4	$1.68M	Sell	45,250 -1,385	-3%	-$49.3K	0.24%	60
2019 Q3	$1.59M	Buy	46,635 +1,178	+3%	+$42.8K	0.26%	51
2019 Q2	$1.87M	Buy	45,457 +4,111	+10%	+$163K	0.34%	45
2019 Q1	$1.67M	Sell	41,346 -695	-2%	-$27.8K	0.33%	45
2018 Q4	$1.74M	Sell	42,041 -527	-1%	-$21.9K	0.43%	39
2018 Q3	$1.78M	Buy	42,568 +917	+2%	+$35.3K	0.28%	54
2018 Q2	$1.43M	Sell	41,651 -1,547	-4%	-$52.9K	0.26%	51
2018 Q1	$1.46M	Buy	43,198 +1,444	+3%	+$49.6K	0.29%	46
2017 Q4	$1.44M	Sell	41,754 -90	-0.2%	-$3.07K	0.2%	57
2017 Q3	$1.42M	Sell	41,844 -415	-1%	-$13.3K	0.24%	50
2017 Q2	$1.35M	Buy	42,259 +17	+0%	+$536	0.23%	50
2017 Q1	$1.37M	Sell	42,242 -211	-0.5%	-$6.65K	0.27%	47
2016 Q4	$1.31M	Hold	42,453	–	–	0.22%	45
2016 Q3	$1.36M	Hold	42,453	–	–	0.28%	49
2016 Q2	$1.42M	Hold	42,453	–	–	0.3%	48
2016 Q1	$1.19M	Hold	42,453	–	–	0.31%	44
2015 Q4	$1.3M	Buy	42,453 +1,182	+3%	+$37.2K	0.31%	45
2015 Q3	$1.23M	Hold	41,271	–	–	0.3%	44
2015 Q2	$1.31M	Buy	41,271 +55	+0.1%	+$1.79K	0.26%	48
2015 Q1	$1.36M	Hold	41,216	–	–	0.27%	46
2014 Q4	$1.22M	Hold	41,216	–	–	0.21%	52
2014 Q3	$1.16M	Sell	41,216 -415	-1%	-$11.6K	0.21%	51
2014 Q2	$1.17M	Sell	41,631 -179	-0.4%	-$5.1K	0.2%	51
2014 Q1	$1.27M	Sell	41,810 -132	-0.3%	-$3.94K	0.23%	46
2013 Q4	$1.22M	Buy	41,942 +162	+0.4%	+$4.71K	0.23%	47
2013 Q3	$1.14M	Hold	41,780	–	–	0.23%	43
2013 Q2	$1.11M	Buy	+41,780	New	+$1.15M	0.25%	32

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Cadinha & Co's PFE Position: Q2 2026 in Review

Cadinha & Co held its Pfizer (PFE) position steady in Q2 2026 at 12,566 shares worth $303K. The position accounts for 0.04% of the portfolio, ranked #83.

Cadinha & Co first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $19.6M in Q4 2022. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Cadinha & Co held 12,566 shares of Pfizer worth $303K as of Q2 2026.
Cadinha & Co left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.04% of Cadinha & Co's portfolio in Q2 2026, its #83 holding.
Cadinha & Co first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
Cadinha & Co's Pfizer position peaked at $19.6M in Q4 2022.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cadinha & Co's 13F filing for Q2 2026, filed 28 Jul 2026.